Rank | Gene Set | Z-score |
---|---|---|
1 | Golgi transport vesicle coating (GO:0048200) | 9.41964858 |
2 | COPI coating of Golgi vesicle (GO:0048205) | 9.41964858 |
3 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 7.74069439 |
4 | protein retention in ER lumen (GO:0006621) | 7.21786483 |
5 | signal peptide processing (GO:0006465) | 6.81567475 |
6 | proteasome assembly (GO:0043248) | 5.07692360 |
7 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.87743577 |
8 | COPII vesicle coating (GO:0048208) | 4.68836605 |
9 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 4.50913728 |
10 | positive regulation of nuclease activity (GO:0032075) | 4.45005087 |
11 | sequestering of metal ion (GO:0051238) | 4.34287806 |
12 | protein maturation by protein folding (GO:0022417) | 4.29434501 |
13 | endoplasmic reticulum unfolded protein response (GO:0030968) | 4.08664687 |
14 | regulation of nuclease activity (GO:0032069) | 4.06922652 |
15 | cellular response to unfolded protein (GO:0034620) | 3.99511390 |
16 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.94675725 |
17 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.94504633 |
18 | cellular response to topologically incorrect protein (GO:0035967) | 3.90324643 |
19 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.82268970 |
20 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.75286182 |
21 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.74905110 |
22 | ribosome assembly (GO:0042255) | 3.74401601 |
23 | ER-nucleus signaling pathway (GO:0006984) | 3.74346733 |
24 | negative regulation of ligase activity (GO:0051352) | 3.73573407 |
25 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.73573407 |
26 | vesicle coating (GO:0006901) | 3.73256075 |
27 | peptidyl-asparagine modification (GO:0018196) | 3.70155972 |
28 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.69254877 |
29 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.68306645 |
30 | keratan sulfate catabolic process (GO:0042340) | 3.67697787 |
31 | protein N-linked glycosylation (GO:0006487) | 3.47648570 |
32 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.39860306 |
33 | neutrophil activation involved in immune response (GO:0002283) | 3.37455141 |
34 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.35217121 |
35 | ATP synthesis coupled proton transport (GO:0015986) | 3.35217121 |
36 | ER to Golgi vesicle-mediated transport (GO:0006888) | 3.32736726 |
37 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.32062208 |
38 | response to endoplasmic reticulum stress (GO:0034976) | 3.31300572 |
39 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.26817388 |
40 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.26817388 |
41 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.24220383 |
42 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.24220383 |
43 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.24220383 |
44 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.21156550 |
45 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.18281426 |
46 | peptide catabolic process (GO:0043171) | 3.18261367 |
47 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.15723590 |
48 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.15723590 |
49 | cullin deneddylation (GO:0010388) | 3.15113300 |
50 | protein neddylation (GO:0045116) | 3.15039136 |
51 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.13836084 |
52 | response to unfolded protein (GO:0006986) | 3.12194401 |
53 | ribosomal large subunit biogenesis (GO:0042273) | 3.10757099 |
54 | cellular response to vitamin D (GO:0071305) | 3.10513148 |
55 | positive regulation of ligase activity (GO:0051351) | 3.09361195 |
56 | response to topologically incorrect protein (GO:0035966) | 3.07797015 |
57 | purine nucleobase biosynthetic process (GO:0009113) | 3.07722115 |
58 | 4-hydroxyproline metabolic process (GO:0019471) | 3.07362017 |
59 | exocrine pancreas development (GO:0031017) | 3.06242996 |
60 | establishment of integrated proviral latency (GO:0075713) | 3.05984856 |
61 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.05854989 |
62 | cell redox homeostasis (GO:0045454) | 3.04269707 |
63 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 3.03003146 |
64 | valine metabolic process (GO:0006573) | 3.01281724 |
65 | regulation of metalloenzyme activity (GO:0048552) | 3.00324225 |
66 | GDP-mannose metabolic process (GO:0019673) | 2.99771976 |
67 | cellular response to vitamin (GO:0071295) | 2.96546760 |
68 | protein deneddylation (GO:0000338) | 2.93303504 |
69 | chaperone-mediated protein folding (GO:0061077) | 2.91379130 |
70 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.89110007 |
71 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.85838385 |
72 | protein autoprocessing (GO:0016540) | 2.84756001 |
73 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.84399722 |
74 | regulation of ligase activity (GO:0051340) | 2.83340942 |
75 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.81242704 |
76 | termination of RNA polymerase III transcription (GO:0006386) | 2.81242704 |
77 | pentose-phosphate shunt (GO:0006098) | 2.80607960 |
78 | collagen fibril organization (GO:0030199) | 2.80602883 |
79 | respiratory electron transport chain (GO:0022904) | 2.80124885 |
80 | nucleotide-sugar metabolic process (GO:0009225) | 2.79041981 |
81 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.78257736 |
82 | NADPH regeneration (GO:0006740) | 2.78158150 |
83 | respiratory chain complex IV assembly (GO:0008535) | 2.77896303 |
84 | protein targeting to mitochondrion (GO:0006626) | 2.74536829 |
85 | purine nucleotide salvage (GO:0032261) | 2.71768764 |
86 | protein targeting to ER (GO:0045047) | 2.71719840 |
87 | cotranslational protein targeting to membrane (GO:0006613) | 2.70650146 |
88 | electron transport chain (GO:0022900) | 2.69830426 |
89 | negative regulation of protein ubiquitination (GO:0031397) | 2.69814781 |
90 | peptidyl-proline hydroxylation (GO:0019511) | 2.68244189 |
91 | apoptotic cell clearance (GO:0043277) | 2.67671126 |
92 | nucleoside salvage (GO:0043174) | 2.67666502 |
93 | formation of translation preinitiation complex (GO:0001731) | 2.66237585 |
94 | ER overload response (GO:0006983) | 2.64889408 |
95 | oxidative phosphorylation (GO:0006119) | 2.64691801 |
96 | protein localization to endoplasmic reticulum (GO:0070972) | 2.64488966 |
97 | mitochondrial calcium ion transport (GO:0006851) | 2.63083520 |
98 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.62997523 |
99 | establishment of viral latency (GO:0019043) | 2.62054125 |
100 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.61908125 |
101 | regulation of cellular amine metabolic process (GO:0033238) | 2.61508525 |
102 | tricarboxylic acid metabolic process (GO:0072350) | 2.59195404 |
103 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.58492316 |
104 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.58144093 |
105 | nucleobase biosynthetic process (GO:0046112) | 2.58050262 |
106 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.57660300 |
107 | misfolded or incompletely synthesized protein catabolic process (GO:0006515) | 2.56634382 |
108 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.56433158 |
109 | proline biosynthetic process (GO:0006561) | 2.56245199 |
110 | peptidyl-histidine modification (GO:0018202) | 2.55725992 |
111 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 2.55194647 |
112 | peptide hormone processing (GO:0016486) | 2.54871535 |
113 | tRNA aminoacylation (GO:0043039) | 2.54619218 |
114 | amino acid activation (GO:0043038) | 2.54619218 |
115 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.53733042 |
116 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.53733042 |
117 | positive regulation of cell cycle arrest (GO:0071158) | 2.52953531 |
118 | translation (GO:0006412) | 2.52735757 |
119 | chaperone-mediated protein transport (GO:0072321) | 2.52393788 |
120 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.52319949 |
121 | membrane budding (GO:0006900) | 2.51822296 |
122 | tRNA aminoacylation for protein translation (GO:0006418) | 2.51454395 |
123 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.51120568 |
124 | glycerol ether metabolic process (GO:0006662) | 2.50402975 |
125 | IMP biosynthetic process (GO:0006188) | 2.48939506 |
126 | protein localization to mitochondrion (GO:0070585) | 2.47783151 |
127 | tricarboxylic acid cycle (GO:0006099) | 2.47687049 |
128 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.47266588 |
129 | cell adhesion mediated by integrin (GO:0033627) | 2.44913667 |
130 | peptidyl-proline modification (GO:0018208) | 2.44768387 |
131 | rRNA modification (GO:0000154) | 2.44080343 |
132 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.43862126 |
133 | protein peptidyl-prolyl isomerization (GO:0000413) | 2.43634374 |
134 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.42709243 |
135 | type B pancreatic cell proliferation (GO:0044342) | 2.42400891 |
136 | regulation of mitochondrial translation (GO:0070129) | 2.42391846 |
137 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.42258059 |
138 | maturation of 5.8S rRNA (GO:0000460) | 2.41770875 |
139 | AMP metabolic process (GO:0046033) | 2.41561068 |
140 | cytochrome complex assembly (GO:0017004) | 2.40857005 |
141 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.37547716 |
142 | response to testosterone (GO:0033574) | 2.36725977 |
143 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.36129771 |
144 | response to misfolded protein (GO:0051788) | 2.35240145 |
145 | maintenance of protein localization in organelle (GO:0072595) | 2.34764657 |
146 | endosome to melanosome transport (GO:0035646) | 2.34073405 |
147 | endosome to pigment granule transport (GO:0043485) | 2.34073405 |
148 | glycosphingolipid catabolic process (GO:0046479) | 2.32453466 |
149 | establishment of protein localization to mitochondrion (GO:0072655) | 2.32262702 |
150 | collagen metabolic process (GO:0032963) | 2.32040842 |
151 | maternal placenta development (GO:0001893) | 2.31440043 |
152 | Golgi organization (GO:0007030) | 2.31348017 |
153 | purine-containing compound salvage (GO:0043101) | 2.31335618 |
154 | ether metabolic process (GO:0018904) | 2.30652821 |
155 | toxin metabolic process (GO:0009404) | 2.29660410 |
156 | lactate metabolic process (GO:0006089) | 2.28558810 |
157 | cell cycle G1/S phase transition (GO:0044843) | 2.27349443 |
158 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.27349443 |
159 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.27196338 |
160 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.26987066 |
161 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.26941228 |
162 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.26490744 |
163 | fucose metabolic process (GO:0006004) | 2.25595991 |
164 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 2.25153146 |
165 | collagen catabolic process (GO:0030574) | 2.24346003 |
166 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.23289502 |
167 | endocrine pancreas development (GO:0031018) | 2.22329892 |
168 | multicellular organismal catabolic process (GO:0044243) | 2.20650752 |
169 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.20429584 |
170 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.19436177 |
171 | glucose catabolic process (GO:0006007) | 2.19220497 |
172 | protein hydroxylation (GO:0018126) | 2.18628200 |
173 | * protein folding (GO:0006457) | 2.17930093 |
174 | type B pancreatic cell development (GO:0003323) | 2.17276104 |
175 | hydrogen peroxide catabolic process (GO:0042744) | 2.17249047 |
176 | multicellular organismal metabolic process (GO:0044236) | 2.17216162 |
177 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.16929614 |
178 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.15351036 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.92219205 |
2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.36702080 |
3 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.30596069 |
4 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.99046539 |
5 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.98469890 |
6 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.84249254 |
7 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.73735082 |
8 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.66983299 |
9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.65705499 |
10 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.45859973 |
11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.44655328 |
12 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.32077940 |
13 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.31851880 |
14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.27977210 |
15 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.11749031 |
16 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.10610994 |
17 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.08554480 |
18 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.05652707 |
19 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.99808287 |
20 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.98530904 |
21 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.94496666 |
22 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.93942108 |
23 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.93119389 |
24 | GATA1_22025678_ChIP-Seq_K562_Human | 1.88200753 |
25 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.88153301 |
26 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.84132248 |
27 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.82324786 |
28 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.80185681 |
29 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.78869179 |
30 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.75026746 |
31 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.74905468 |
32 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.73375425 |
33 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.72420296 |
34 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.72399618 |
35 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.71606189 |
36 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.68196498 |
37 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.66947600 |
38 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.66536592 |
39 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.66487102 |
40 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.64964179 |
41 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61196048 |
42 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.59154159 |
43 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.58251873 |
44 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.54353086 |
45 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.54310987 |
46 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.54265179 |
47 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.54166362 |
48 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.51792786 |
49 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.50355466 |
50 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.50101421 |
51 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.49143361 |
52 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.49027756 |
53 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.48727202 |
54 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.47151521 |
55 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.46921226 |
56 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.46847303 |
57 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.46323497 |
58 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.44786655 |
59 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.42918254 |
60 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.42526939 |
61 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42167967 |
62 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.42085409 |
63 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.39398315 |
64 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.39087571 |
65 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38923881 |
66 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.38657617 |
67 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.37635381 |
68 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.35578770 |
69 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.35100865 |
70 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.33986213 |
71 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.33098412 |
72 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.32318795 |
73 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.31159925 |
74 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.30420191 |
75 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.29917919 |
76 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.28906570 |
77 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.25257019 |
78 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.24434281 |
79 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.21477460 |
80 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.21129800 |
81 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.19005168 |
82 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.19003274 |
83 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.18801114 |
84 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.17607303 |
85 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.16770484 |
86 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.15294703 |
87 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.14519997 |
88 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.14180287 |
89 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.12867961 |
90 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.12684756 |
91 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.11332301 |
92 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.08995687 |
93 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.08468954 |
94 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.08252836 |
95 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.08018322 |
96 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.07894673 |
97 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.06999375 |
98 | ATF3_27146783_Chip-Seq_COLON_Human | 1.06797551 |
99 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.05801395 |
100 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.05337909 |
101 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.05273887 |
102 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.04846609 |
103 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.03904291 |
104 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.03796955 |
105 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.03510331 |
106 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.03507037 |
107 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.02433666 |
108 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.02364441 |
109 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.01763771 |
110 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01378008 |
111 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.00973681 |
112 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.99587140 |
113 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.97950239 |
114 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.97536127 |
115 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.95329224 |
116 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.94878091 |
117 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.93810301 |
118 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.93756267 |
119 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.93632651 |
120 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.93616449 |
121 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.93251076 |
122 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.93002216 |
123 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.92746970 |
124 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.92158550 |
125 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.91636921 |
126 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.91215235 |
127 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.90078837 |
128 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.89481394 |
129 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.89316584 |
130 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.88067815 |
131 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.86228923 |
132 | MYB_26560356_Chip-Seq_TH2_Human | 0.86160867 |
133 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.82630779 |
134 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.82431859 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0008438_abnormal_cutaneous_collagen | 5.67420623 |
2 | MP0006054_spinal_hemorrhage | 3.98944958 |
3 | MP0005275_abnormal_skin_tensile | 3.11559787 |
4 | MP0005503_abnormal_tendon_morphology | 2.90408068 |
5 | MP0001835_abnormal_antigen_presentation | 2.46671065 |
6 | MP0003705_abnormal_hypodermis_morpholog | 2.43773731 |
7 | MP0003806_abnormal_nucleotide_metabolis | 2.41408552 |
8 | MP0002877_abnormal_melanocyte_morpholog | 2.41265449 |
9 | MP0003195_calcinosis | 2.40901950 |
10 | MP0000013_abnormal_adipose_tissue | 2.34119043 |
11 | MP0003279_aneurysm | 2.32242533 |
12 | MP0005220_abnormal_exocrine_pancreas | 2.30399621 |
13 | MP0001958_emphysema | 2.25716838 |
14 | MP0004272_abnormal_basement_membrane | 2.19114364 |
15 | MP0005058_abnormal_lysosome_morphology | 2.16336257 |
16 | MP0009785_altered_susceptibility_to | 2.15577340 |
17 | MP0006082_CNS_inflammation | 2.07358039 |
18 | MP0003186_abnormal_redox_activity | 2.04105726 |
19 | MP0002148_abnormal_hypersensitivity_rea | 2.02498544 |
20 | MP0006036_abnormal_mitochondrial_physio | 2.01759814 |
21 | MP0009697_abnormal_copulation | 1.97676601 |
22 | MP0003786_premature_aging | 1.86741205 |
23 | MP0009384_cardiac_valve_regurgitation | 1.85266307 |
24 | MP0003300_gastrointestinal_ulcer | 1.75754118 |
25 | MP0008058_abnormal_DNA_repair | 1.75038794 |
26 | MP0010094_abnormal_chromosome_stability | 1.66257098 |
27 | MP0005671_abnormal_response_to | 1.63297609 |
28 | MP0001542_abnormal_bone_strength | 1.61187420 |
29 | MP0002295_abnormal_pulmonary_circulatio | 1.58961548 |
30 | MP0002896_abnormal_bone_mineralization | 1.57303182 |
31 | MP0003183_abnormal_peptide_metabolism | 1.56992898 |
32 | MP0009333_abnormal_splenocyte_physiolog | 1.54613001 |
33 | MP0005023_abnormal_wound_healing | 1.49400760 |
34 | MP0002139_abnormal_hepatobiliary_system | 1.48129190 |
35 | MP0003566_abnormal_cell_adhesion | 1.47974379 |
36 | MP0009643_abnormal_urine_homeostasis | 1.47754369 |
37 | MP0002006_tumorigenesis | 1.45137161 |
38 | MP0005000_abnormal_immune_tolerance | 1.43235006 |
39 | MP0005408_hypopigmentation | 1.39498325 |
40 | MP0001944_abnormal_pancreas_morphology | 1.37775213 |
41 | MP0004147_increased_porphyrin_level | 1.35927294 |
42 | MP0010352_gastrointestinal_tract_polyps | 1.35456606 |
43 | MP0001533_abnormal_skeleton_physiology | 1.35081133 |
44 | MP0009840_abnormal_foam_cell | 1.35018111 |
45 | MP0002419_abnormal_innate_immunity | 1.33748063 |
46 | MP0001845_abnormal_inflammatory_respons | 1.33303493 |
47 | MP0003283_abnormal_digestive_organ | 1.31605449 |
48 | MP0002090_abnormal_vision | 1.31517577 |
49 | MP0005084_abnormal_gallbladder_morpholo | 1.28795254 |
50 | MP0005464_abnormal_platelet_physiology | 1.28657121 |
51 | MP0001666_abnormal_nutrient_absorption | 1.27831680 |
52 | MP0000685_abnormal_immune_system | 1.25917191 |
53 | MP0010368_abnormal_lymphatic_system | 1.23982353 |
54 | MP0002060_abnormal_skin_morphology | 1.23278443 |
55 | MP0002452_abnormal_antigen_presenting | 1.22967140 |
56 | MP0000343_altered_response_to | 1.22948207 |
57 | MP0002132_abnormal_respiratory_system | 1.22922505 |
58 | MP0003448_altered_tumor_morphology | 1.22545837 |
59 | MP0001756_abnormal_urination | 1.22333315 |
60 | MP0004043_abnormal_pH_regulation | 1.22241045 |
61 | MP0010155_abnormal_intestine_physiology | 1.21080420 |
62 | MP0003795_abnormal_bone_structure | 1.17940962 |
63 | MP0005508_abnormal_skeleton_morphology | 1.17909665 |
64 | MP0003077_abnormal_cell_cycle | 1.17524605 |
65 | MP0001790_abnormal_immune_system | 1.16398409 |
66 | MP0005387_immune_system_phenotype | 1.16398409 |
67 | MP0003724_increased_susceptibility_to | 1.13591247 |
68 | MP0009780_abnormal_chondrocyte_physiolo | 1.13106655 |
69 | MP0005025_abnormal_response_to | 1.11471302 |
70 | MP0005365_abnormal_bile_salt | 1.11087946 |
71 | MP0005083_abnormal_biliary_tract | 1.10152969 |
72 | MP0002693_abnormal_pancreas_physiology | 1.09590401 |
73 | MP0002396_abnormal_hematopoietic_system | 1.09232634 |
74 | MP0002723_abnormal_immune_serum | 1.09166581 |
75 | MP0002933_joint_inflammation | 1.09145005 |
76 | MP0005390_skeleton_phenotype | 1.08676541 |
77 | MP0001764_abnormal_homeostasis | 1.08621172 |
78 | MP0003075_altered_response_to | 1.07305358 |
79 | MP0005085_abnormal_gallbladder_physiolo | 1.06345631 |
80 | MP0001800_abnormal_humoral_immune | 1.05599287 |
81 | MP0001243_abnormal_dermal_layer | 1.05324118 |
82 | MP0003111_abnormal_nucleus_morphology | 1.04353659 |
83 | MP0000163_abnormal_cartilage_morphology | 1.03299865 |
84 | MP0008932_abnormal_embryonic_tissue | 1.02666489 |
85 | MP0002420_abnormal_adaptive_immunity | 0.99525331 |
86 | MP0004782_abnormal_surfactant_physiolog | 0.98860567 |
87 | MP0005332_abnormal_amino_acid | 0.98720705 |
88 | MP0001819_abnormal_immune_cell | 0.98622112 |
89 | MP0005636_abnormal_mineral_homeostasis | 0.98210956 |
90 | MP0003656_abnormal_erythrocyte_physiolo | 0.98069465 |
91 | MP0003191_abnormal_cellular_cholesterol | 0.97194890 |
92 | MP0000003_abnormal_adipose_tissue | 0.97138896 |
93 | MP0000490_abnormal_crypts_of | 0.96518376 |
94 | MP0001879_abnormal_lymphatic_vessel | 0.95031712 |
95 | MP0000465_gastrointestinal_hemorrhage | 0.94884428 |
96 | MP0005166_decreased_susceptibility_to | 0.94177941 |
97 | MP0003950_abnormal_plasma_membrane | 0.93972945 |
98 | MP0000858_altered_metastatic_potential | 0.93930909 |
99 | MP0003252_abnormal_bile_duct | 0.93894301 |
100 | MP0008873_increased_physiological_sensi | 0.92492766 |
101 | MP0002115_abnormal_skeleton_extremities | 0.92070324 |
102 | MP0003693_abnormal_embryo_hatching | 0.91906748 |
103 | MP0005164_abnormal_response_to | 0.91785006 |
104 | MP0010386_abnormal_urinary_bladder | 0.91559925 |
105 | MP0005379_endocrine/exocrine_gland_phen | 0.91301515 |
106 | MP0009764_decreased_sensitivity_to | 0.89805883 |
107 | MP0002405_respiratory_system_inflammati | 0.88451606 |
108 | MP0003718_maternal_effect | 0.88351529 |
109 | MP0001661_extended_life_span | 0.87589801 |
110 | MP0000372_irregular_coat_pigmentation | 0.86938645 |
111 | MP0005360_urolithiasis | 0.86323658 |
112 | MP0010234_abnormal_vibrissa_follicle | 0.86288585 |
113 | MP0003172_abnormal_lysosome_physiology | 0.85633763 |
114 | MP0004957_abnormal_blastocyst_morpholog | 0.84530231 |
115 | MP0002113_abnormal_skeleton_development | 0.84160509 |
116 | MP0000689_abnormal_spleen_morphology | 0.84141321 |
117 | MP0005257_abnormal_intraocular_pressure | 0.84029162 |
118 | MP0005075_abnormal_melanosome_morpholog | 0.83954289 |
119 | MP0001881_abnormal_mammary_gland | 0.83507240 |
120 | MP0009763_increased_sensitivity_to | 0.83320054 |
121 | MP0002909_abnormal_adrenal_gland | 0.82078776 |
122 | MP0004134_abnormal_chest_morphology | 0.82026811 |
123 | MP0005319_abnormal_enzyme/_coenzyme | 0.81970225 |
124 | MP0002928_abnormal_bile_duct | 0.81225382 |
125 | MP0002019_abnormal_tumor_incidence | 0.79260556 |
126 | MP0002398_abnormal_bone_marrow | 0.79075675 |
127 | MP0000358_abnormal_cell_content/ | 0.78497336 |
128 | MP0002168_other_aberrant_phenotype | 0.78390105 |
129 | MP0008260_abnormal_autophagy | 0.77289196 |
130 | MP0003436_decreased_susceptibility_to | 0.74075813 |
131 | MP0000598_abnormal_liver_morphology | 0.73741166 |
132 | MP0005165_increased_susceptibility_to | 0.71204311 |
133 | MP0002998_abnormal_bone_remodeling | 0.70459348 |
134 | MP0004264_abnormal_extraembryonic_tissu | 0.70380175 |
135 | MP0008007_abnormal_cellular_replicative | 0.70370442 |
136 | MP0001299_abnormal_eye_distance/ | 0.69503260 |
137 | MP0002166_altered_tumor_susceptibility | 0.68534990 |
138 | MP0002078_abnormal_glucose_homeostasis | 0.67840528 |
139 | MP0002135_abnormal_kidney_morphology | 0.67787769 |
140 | MP0008004_abnormal_stomach_pH | 0.65973622 |
141 | MP0000613_abnormal_salivary_gland | 0.65739803 |
142 | MP0002136_abnormal_kidney_physiology | 0.65424241 |
143 | MP0000609_abnormal_liver_physiology | 0.65053560 |
144 | MP0001915_intracranial_hemorrhage | 0.64929670 |
145 | MP0003091_abnormal_cell_migration | 0.63551213 |
146 | MP0002282_abnormal_trachea_morphology | 0.63322506 |
147 | MP0000767_abnormal_smooth_muscle | 0.63290077 |
148 | MP0001853_heart_inflammation | 0.62518180 |
149 | MP0008469_abnormal_protein_level | 0.60348338 |
150 | MP0003868_abnormal_feces_composition | 0.59240591 |
151 | MP0000681_abnormal_thyroid_gland | 0.59116951 |
152 | MP0003959_abnormal_lean_body | 0.58898009 |
153 | MP0001765_abnormal_ion_homeostasis | 0.57932981 |
154 | MP0000537_abnormal_urethra_morphology | 0.57414179 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Protrusio acetabuli (HP:0003179) | 4.73006384 |
2 | Premature rupture of membranes (HP:0001788) | 4.45979505 |
3 | Cervical subluxation (HP:0003308) | 3.88486972 |
4 | Beaking of vertebral bodies (HP:0004568) | 3.81451875 |
5 | Hypoglycemic coma (HP:0001325) | 3.66912323 |
6 | Vacuolated lymphocytes (HP:0001922) | 3.55132496 |
7 | Abnormality of the intrinsic pathway (HP:0010989) | 3.49416856 |
8 | Vertebral compression fractures (HP:0002953) | 3.40853577 |
9 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.33609764 |
10 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.33609764 |
11 | Abnormality of glycolipid metabolism (HP:0010969) | 3.33609764 |
12 | Generalized aminoaciduria (HP:0002909) | 3.29129231 |
13 | Increased hepatocellular lipid droplets (HP:0006565) | 3.27104064 |
14 | Dysostosis multiplex (HP:0000943) | 3.26727178 |
15 | Acute necrotizing encephalopathy (HP:0006965) | 3.24009494 |
16 | Abnormality of methionine metabolism (HP:0010901) | 3.18285438 |
17 | Mucopolysacchariduria (HP:0008155) | 3.10028845 |
18 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.10028845 |
19 | Soft skin (HP:0000977) | 3.04904221 |
20 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.03059103 |
21 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.03059103 |
22 | Thoracolumbar scoliosis (HP:0002944) | 2.95586779 |
23 | Lipid accumulation in hepatocytes (HP:0006561) | 2.95458015 |
24 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.94706574 |
25 | Aortic dissection (HP:0002647) | 2.94586587 |
26 | Progressive macrocephaly (HP:0004481) | 2.93602875 |
27 | Increased CSF lactate (HP:0002490) | 2.91898267 |
28 | Mitochondrial inheritance (HP:0001427) | 2.90603966 |
29 | Hepatic necrosis (HP:0002605) | 2.90364487 |
30 | Renal Fanconi syndrome (HP:0001994) | 2.88918823 |
31 | Abnormality of dentin (HP:0010299) | 2.84508906 |
32 | Aortic aneurysm (HP:0004942) | 2.82682649 |
33 | Acute encephalopathy (HP:0006846) | 2.80202485 |
34 | Ankle contracture (HP:0006466) | 2.80097683 |
35 | Hepatocellular necrosis (HP:0001404) | 2.73246530 |
36 | Biconcave vertebral bodies (HP:0004586) | 2.70627284 |
37 | Wormian bones (HP:0002645) | 2.67669934 |
38 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.65209244 |
39 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.65209244 |
40 | Abnormal protein glycosylation (HP:0012346) | 2.65209244 |
41 | Abnormal glycosylation (HP:0012345) | 2.65209244 |
42 | Nonimmune hydrops fetalis (HP:0001790) | 2.65187971 |
43 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.59988699 |
44 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.59988699 |
45 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.59988699 |
46 | Hypoglycemic seizures (HP:0002173) | 2.59026102 |
47 | Cerebral edema (HP:0002181) | 2.57149452 |
48 | Palpitations (HP:0001962) | 2.55908182 |
49 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.55357399 |
50 | Disinhibition (HP:0000734) | 2.54703251 |
51 | Joint stiffness (HP:0001387) | 2.50907894 |
52 | Exertional dyspnea (HP:0002875) | 2.43858906 |
53 | Platyspondyly (HP:0000926) | 2.43820512 |
54 | Increased serum pyruvate (HP:0003542) | 2.42723066 |
55 | Abnormal foot bone ossification (HP:0010675) | 2.42414602 |
56 | Hepatosplenomegaly (HP:0001433) | 2.41082393 |
57 | Poor head control (HP:0002421) | 2.39160746 |
58 | Epiphyseal dysplasia (HP:0002656) | 2.36602852 |
59 | Blue sclerae (HP:0000592) | 2.33168543 |
60 | B lymphocytopenia (HP:0010976) | 2.33142914 |
61 | Nausea (HP:0002018) | 2.33046034 |
62 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.30978245 |
63 | Abnormal tarsal ossification (HP:0008369) | 2.29843580 |
64 | Type I transferrin isoform profile (HP:0003642) | 2.28673059 |
65 | Atrophic scars (HP:0001075) | 2.27208017 |
66 | Megaloblastic anemia (HP:0001889) | 2.26580000 |
67 | Conjunctival hamartoma (HP:0100780) | 2.24688835 |
68 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.22939590 |
69 | Single umbilical artery (HP:0001195) | 2.22939590 |
70 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.22939590 |
71 | 3-Methylglutaconic aciduria (HP:0003535) | 2.22496905 |
72 | Peritonitis (HP:0002586) | 2.22412600 |
73 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.22087366 |
74 | Respiratory failure (HP:0002878) | 2.20975008 |
75 | Protuberant abdomen (HP:0001538) | 2.19936384 |
76 | Hypoplasia of the odontoid process (HP:0003311) | 2.19691542 |
77 | Abnormality of the acetabulum (HP:0003170) | 2.19678463 |
78 | Reduced antithrombin III activity (HP:0001976) | 2.19481284 |
79 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.18957482 |
80 | Abnormality of the common coagulation pathway (HP:0010990) | 2.18688091 |
81 | Symptomatic seizures (HP:0011145) | 2.18347227 |
82 | Agnosia (HP:0010524) | 2.17183265 |
83 | Increased serum lactate (HP:0002151) | 2.15885298 |
84 | Lactic acidosis (HP:0003128) | 2.14510413 |
85 | Dilatation of the ascending aorta (HP:0005111) | 2.13559677 |
86 | Increased intramyocellular lipid droplets (HP:0012240) | 2.13357942 |
87 | Recurrent abscess formation (HP:0002722) | 2.12967340 |
88 | Abnormal cartilage morphology (HP:0002763) | 2.11773153 |
89 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.10832576 |
90 | Methylmalonic acidemia (HP:0002912) | 2.10451284 |
91 | Abnormality of glycolysis (HP:0004366) | 2.08776502 |
92 | Glucose intolerance (HP:0000833) | 2.08703030 |
93 | Vascular tortuosity (HP:0004948) | 2.08631338 |
94 | Petechiae (HP:0000967) | 2.08476498 |
95 | Hypokinesia (HP:0002375) | 2.07561295 |
96 | Osteolytic defects of the hand bones (HP:0009699) | 2.06683000 |
97 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.06683000 |
98 | Posterior subcapsular cataract (HP:0007787) | 2.06600447 |
99 | Abnormality of the umbilical cord (HP:0010881) | 2.03397513 |
100 | Thrombocytosis (HP:0001894) | 2.02742027 |
101 | Neoplasm of head and neck (HP:0012288) | 2.00949589 |
102 | Esophageal neoplasm (HP:0100751) | 2.00949589 |
103 | Disproportionate short-trunk short stature (HP:0003521) | 2.00554206 |
104 | Osteoarthritis (HP:0002758) | 2.00194095 |
105 | Ketoacidosis (HP:0001993) | 1.98584162 |
106 | Abnormality of B cell number (HP:0010975) | 1.96398627 |
107 | Hypoproteinemia (HP:0003075) | 1.95705410 |
108 | Abnormality of vitamin B metabolism (HP:0004340) | 1.94050992 |
109 | CNS demyelination (HP:0007305) | 1.93318195 |
110 | Rough bone trabeculation (HP:0100670) | 1.92942902 |
111 | Exercise intolerance (HP:0003546) | 1.92548797 |
112 | Lethargy (HP:0001254) | 1.91738141 |
113 | Abnormality of the odontoid process (HP:0003310) | 1.91119675 |
114 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.90363082 |
115 | Degeneration of anterior horn cells (HP:0002398) | 1.90208887 |
116 | Abnormality of the anterior horn cell (HP:0006802) | 1.90208887 |
117 | Abnormality of urine glucose concentration (HP:0011016) | 1.90079947 |
118 | Glycosuria (HP:0003076) | 1.90079947 |
119 | Cerebral aneurysm (HP:0004944) | 1.89258992 |
120 | Cupped ribs (HP:0000887) | 1.88950450 |
121 | Secondary amenorrhea (HP:0000869) | 1.88879588 |
122 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.88792653 |
123 | Steatorrhea (HP:0002570) | 1.88763870 |
124 | Tetraparesis (HP:0002273) | 1.88509892 |
125 | Increased cerebral lipofuscin (HP:0011813) | 1.88258282 |
126 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.86858624 |
127 | Irregular vertebral endplates (HP:0003301) | 1.86647082 |
128 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.85857479 |
129 | Congenital, generalized hypertrichosis (HP:0004540) | 1.85666938 |
130 | Progressive external ophthalmoplegia (HP:0000590) | 1.85061669 |
131 | Microvesicular hepatic steatosis (HP:0001414) | 1.84832185 |
132 | Abnormality of the basal ganglia (HP:0002134) | 1.84636366 |
133 | Metaphyseal dysplasia (HP:0100255) | 1.84380821 |
134 | T lymphocytopenia (HP:0005403) | 1.83711203 |
135 | Abnormality of the calcaneus (HP:0008364) | 1.83657638 |
136 | Ovoid vertebral bodies (HP:0003300) | 1.83624947 |
137 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.83598536 |
138 | Patchy hypopigmentation of hair (HP:0011365) | 1.83145621 |
139 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.83127427 |
140 | Axonal loss (HP:0003447) | 1.83017966 |
141 | Abnormality of renal resorption (HP:0011038) | 1.82816747 |
142 | Abnormality of the lumbar spine (HP:0100712) | 1.82004425 |
143 | Loss of speech (HP:0002371) | 1.81883072 |
144 | Respiratory difficulties (HP:0002880) | 1.80768052 |
145 | Interstitial pulmonary disease (HP:0006530) | 1.80765877 |
146 | Methylmalonic aciduria (HP:0012120) | 1.79608124 |
147 | Aplastic anemia (HP:0001915) | 1.79468658 |
148 | Severe short stature (HP:0003510) | 1.79026534 |
149 | Macrocytic anemia (HP:0001972) | 1.78941370 |
150 | Upper motor neuron abnormality (HP:0002127) | 1.78793901 |
151 | Abdominal distention (HP:0003270) | 1.78680764 |
152 | Microretrognathia (HP:0000308) | 1.77923315 |
153 | Late onset (HP:0003584) | 1.77833298 |
154 | Coxa vara (HP:0002812) | 1.77454499 |
155 | Arterial tortuosity (HP:0005116) | 1.76178074 |
156 | Bladder diverticulum (HP:0000015) | 1.76024018 |
157 | Progressive neurologic deterioration (HP:0002344) | 1.75903526 |
158 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.73303857 |
159 | Neonatal short-limb short stature (HP:0008921) | 1.72973813 |
160 | Fragile skin (HP:0001030) | 1.72874777 |
161 | Back pain (HP:0003418) | 1.70728965 |
162 | Spinal rigidity (HP:0003306) | 1.70538900 |
163 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.68820851 |
164 | Epiphyseal stippling (HP:0010655) | 1.67165497 |
165 | Metaphyseal cupping (HP:0003021) | 1.66716986 |
166 | Ectopia lentis (HP:0001083) | 1.65120639 |
167 | Thin bony cortex (HP:0002753) | 1.65022467 |
168 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.64662048 |
169 | Vertebral hypoplasia (HP:0008417) | 1.64662048 |
170 | Aplasia/Hypoplasia involving the vertebral column (HP:0008518) | 1.62767819 |
171 | Hyperglycemia (HP:0003074) | 1.62703733 |
172 | Chondrocalcinosis (HP:0000934) | 1.62325365 |
173 | Follicular hyperkeratosis (HP:0007502) | 1.61858218 |
174 | Multiple enchondromatosis (HP:0005701) | 1.61295669 |
175 | Abnormality of subcutaneous fat tissue (HP:0001001) | 1.60290875 |
176 | Irregular epiphyses (HP:0010582) | 1.59900612 |
177 | Coxa valga (HP:0002673) | 1.59897498 |
178 | Gout (HP:0001997) | 1.59885092 |
Rank | Gene Set | Z-score |
---|---|---|
1 | SCYL2 | 3.44677825 |
2 | ERN1 | 3.33803601 |
3 | MAP3K12 | 3.08423133 |
4 | TESK1 | 2.98524346 |
5 | EIF2AK3 | 2.95257727 |
6 | NME2 | 2.90849029 |
7 | BCKDK | 2.86521539 |
8 | TESK2 | 2.69607869 |
9 | TRIB3 | 2.62743804 |
10 | PASK | 2.57456825 |
11 | EIF2AK1 | 2.23569701 |
12 | FRK | 2.23177792 |
13 | SRPK1 | 2.18065697 |
14 | LIMK1 | 2.14784327 |
15 | BMPR2 | 2.12411005 |
16 | FLT3 | 2.00332376 |
17 | TRIM28 | 1.95033527 |
18 | LRRK2 | 1.94750539 |
19 | MST4 | 1.69046665 |
20 | PAK4 | 1.65548395 |
21 | PIM2 | 1.62693796 |
22 | CAMKK2 | 1.60243115 |
23 | PIK3CG | 1.54612799 |
24 | KDR | 1.53722356 |
25 | TSSK6 | 1.53586423 |
26 | RPS6KA4 | 1.52529025 |
27 | BRSK2 | 1.49330100 |
28 | PKN2 | 1.48697755 |
29 | MAP3K3 | 1.45253337 |
30 | DDR2 | 1.45186657 |
31 | NEK9 | 1.43177042 |
32 | VRK2 | 1.41880860 |
33 | SIK3 | 1.41742578 |
34 | MAPK15 | 1.41350871 |
35 | MET | 1.40020430 |
36 | PDGFRA | 1.37526608 |
37 | INSRR | 1.33998135 |
38 | EPHA2 | 1.29784840 |
39 | TGFBR2 | 1.28331280 |
40 | MAP3K14 | 1.27883346 |
41 | PTK6 | 1.27324363 |
42 | TTK | 1.25481802 |
43 | BUB1 | 1.16890436 |
44 | ILK | 1.16622174 |
45 | TAOK3 | 1.14103678 |
46 | MAPKAPK3 | 1.12628477 |
47 | PLK3 | 1.12397030 |
48 | TRPM7 | 1.09589810 |
49 | ERBB3 | 1.07463091 |
50 | TTN | 1.06638767 |
51 | PAK2 | 1.06562112 |
52 | MAP3K2 | 1.05267250 |
53 | MKNK1 | 0.99726619 |
54 | MYLK | 0.99632095 |
55 | BMPR1B | 0.98917187 |
56 | ARAF | 0.98657738 |
57 | PTK2 | 0.98516268 |
58 | STK16 | 0.98119626 |
59 | MOS | 0.97793289 |
60 | EPHA3 | 0.97078844 |
61 | WNK4 | 0.96501867 |
62 | ERBB4 | 0.94826887 |
63 | TGFBR1 | 0.93726500 |
64 | NEK1 | 0.86662332 |
65 | ZAP70 | 0.86388970 |
66 | FER | 0.85264601 |
67 | LATS1 | 0.83358127 |
68 | EIF2AK2 | 0.80339631 |
69 | MAP3K8 | 0.79933645 |
70 | SIK1 | 0.78357019 |
71 | TBK1 | 0.77573262 |
72 | STK10 | 0.75908974 |
73 | MAP2K3 | 0.75896135 |
74 | PLK4 | 0.75397072 |
75 | CDK6 | 0.74428353 |
76 | DYRK3 | 0.73579299 |
77 | PRKG2 | 0.71602223 |
78 | MAP2K2 | 0.70943750 |
79 | VRK1 | 0.70452059 |
80 | CLK1 | 0.69835464 |
81 | PBK | 0.67836239 |
82 | PDK2 | 0.67182159 |
83 | BCR | 0.64344816 |
84 | TXK | 0.63961173 |
85 | JAK3 | 0.63016580 |
86 | ABL2 | 0.62937588 |
87 | DAPK1 | 0.62545488 |
88 | DYRK1B | 0.62226094 |
89 | HIPK2 | 0.61904073 |
90 | WEE1 | 0.61866583 |
91 | NTRK1 | 0.60172527 |
92 | TEC | 0.59002706 |
93 | EPHB1 | 0.56428557 |
94 | MAP2K6 | 0.55870236 |
95 | CSNK1G1 | 0.55129603 |
96 | BRAF | 0.54830724 |
97 | ACVR1B | 0.54277497 |
98 | GRK1 | 0.53968231 |
99 | STK4 | 0.53766980 |
100 | PLK1 | 0.52184153 |
101 | MST1R | 0.50348715 |
102 | CSNK2A1 | 0.49902162 |
103 | RPS6KB2 | 0.49632911 |
104 | NUAK1 | 0.49486130 |
105 | CSNK2A2 | 0.49095474 |
106 | PAK1 | 0.48799113 |
107 | JAK1 | 0.48311458 |
108 | STK3 | 0.48011893 |
109 | GRK7 | 0.47809060 |
110 | AURKB | 0.46074574 |
111 | CCNB1 | 0.44812076 |
112 | TYK2 | 0.44072087 |
113 | BTK | 0.43509681 |
114 | EEF2K | 0.43439456 |
115 | MAPKAPK5 | 0.43312090 |
116 | MAP2K1 | 0.40645810 |
117 | MKNK2 | 0.40604962 |
118 | IKBKB | 0.37480354 |
119 | TIE1 | 0.37028960 |
120 | KIT | 0.35978371 |
121 | BRSK1 | 0.35889874 |
122 | IRAK1 | 0.35633720 |
123 | PAK3 | 0.35254913 |
124 | LYN | 0.34359002 |
125 | CDK9 | 0.34177057 |
126 | CSNK1G3 | 0.33770413 |
127 | CSNK1A1L | 0.31796729 |
128 | ALK | 0.29982074 |
129 | ZAK | 0.29964962 |
130 | CSF1R | 0.29735806 |
131 | RET | 0.29348320 |
132 | IGF1R | 0.28927157 |
133 | GSK3A | 0.28872411 |
134 | ABL1 | 0.28669564 |
135 | PLK2 | 0.28261031 |
136 | IRAK3 | 0.27613875 |
137 | NLK | 0.27257541 |
138 | CSNK1G2 | 0.26001082 |
139 | CDK8 | 0.25701427 |
140 | PRKCI | 0.25438980 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Protein export_Homo sapiens_hsa03060 | 5.95043570 |
2 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 3.57525411 |
3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.45839116 |
4 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.12553945 |
5 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.82708913 |
6 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.63773430 |
7 | Proteasome_Homo sapiens_hsa03050 | 2.28951250 |
8 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.17310342 |
9 | Other glycan degradation_Homo sapiens_hsa00511 | 2.15512806 |
10 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.11109509 |
11 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.08871891 |
12 | Lysosome_Homo sapiens_hsa04142 | 2.08688943 |
13 | Parkinsons disease_Homo sapiens_hsa05012 | 2.07302115 |
14 | RNA polymerase_Homo sapiens_hsa03020 | 1.90065471 |
15 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.87105023 |
16 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.78848033 |
17 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.72939067 |
18 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.71177993 |
19 | Asthma_Homo sapiens_hsa05310 | 1.70945125 |
20 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.57894789 |
21 | Allograft rejection_Homo sapiens_hsa05330 | 1.54386036 |
22 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.52404406 |
23 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.50754151 |
24 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.50236307 |
25 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.46778242 |
26 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.42443333 |
27 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.41378324 |
28 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.33212320 |
29 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.33158458 |
30 | Huntingtons disease_Homo sapiens_hsa05016 | 1.31787951 |
31 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.31520714 |
32 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.30900714 |
33 | Spliceosome_Homo sapiens_hsa03040 | 1.27625264 |
34 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.26815182 |
35 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.25379620 |
36 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.23406425 |
37 | Alzheimers disease_Homo sapiens_hsa05010 | 1.22756698 |
38 | Homologous recombination_Homo sapiens_hsa03440 | 1.21976025 |
39 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.21544360 |
40 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.21122915 |
41 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.19158966 |
42 | Legionellosis_Homo sapiens_hsa05134 | 1.14766442 |
43 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.13288578 |
44 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.13018744 |
45 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.12055787 |
46 | DNA replication_Homo sapiens_hsa03030 | 1.11249147 |
47 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.09309268 |
48 | Ribosome_Homo sapiens_hsa03010 | 1.06199419 |
49 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.03582359 |
50 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.03298176 |
51 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.02479216 |
52 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.00975573 |
53 | Basal transcription factors_Homo sapiens_hsa03022 | 0.99173882 |
54 | Phagosome_Homo sapiens_hsa04145 | 0.98402099 |
55 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.96526900 |
56 | RNA degradation_Homo sapiens_hsa03018 | 0.94652065 |
57 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.94461874 |
58 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.94366076 |
59 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.92920527 |
60 | Peroxisome_Homo sapiens_hsa04146 | 0.92848153 |
61 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.92805743 |
62 | Focal adhesion_Homo sapiens_hsa04510 | 0.89908684 |
63 | Galactose metabolism_Homo sapiens_hsa00052 | 0.89253014 |
64 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.88657299 |
65 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.85934317 |
66 | Purine metabolism_Homo sapiens_hsa00230 | 0.85751325 |
67 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.85055236 |
68 | Viral myocarditis_Homo sapiens_hsa05416 | 0.85046808 |
69 | Carbon metabolism_Homo sapiens_hsa01200 | 0.83985292 |
70 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.82014186 |
71 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.79797728 |
72 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.78445269 |
73 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.78051383 |
74 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.77994423 |
75 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.77044478 |
76 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.75576513 |
77 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.74809689 |
78 | Malaria_Homo sapiens_hsa05144 | 0.74353975 |
79 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.74086216 |
80 | Sulfur relay system_Homo sapiens_hsa04122 | 0.74061537 |
81 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.72055060 |
82 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.71705344 |
83 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.70318923 |
84 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.69574719 |
85 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.69545009 |
86 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.69160674 |
87 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.68212116 |
88 | Bladder cancer_Homo sapiens_hsa05219 | 0.64026165 |
89 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.62933420 |
90 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.61015619 |
91 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.60661757 |
92 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.59954193 |
93 | Thyroid cancer_Homo sapiens_hsa05216 | 0.59886061 |
94 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.59651072 |
95 | Shigellosis_Homo sapiens_hsa05131 | 0.59011668 |
96 | Histidine metabolism_Homo sapiens_hsa00340 | 0.58020302 |
97 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.58013798 |
98 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.55492910 |
99 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.53812387 |
100 | Leishmaniasis_Homo sapiens_hsa05140 | 0.53479440 |
101 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.50748317 |
102 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.50428188 |
103 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.50366645 |
104 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.49949683 |
105 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.49658284 |
106 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.49322088 |
107 | Metabolic pathways_Homo sapiens_hsa01100 | 0.48565153 |
108 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.46978069 |
109 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.45578097 |
110 | Mismatch repair_Homo sapiens_hsa03430 | 0.45281701 |
111 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.44211026 |
112 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.43528118 |
113 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.42875336 |
114 | Amoebiasis_Homo sapiens_hsa05146 | 0.42722113 |
115 | Pertussis_Homo sapiens_hsa05133 | 0.42606835 |
116 | Cell cycle_Homo sapiens_hsa04110 | 0.40948764 |
117 | Base excision repair_Homo sapiens_hsa03410 | 0.40677914 |
118 | Mineral absorption_Homo sapiens_hsa04978 | 0.40342882 |
119 | Apoptosis_Homo sapiens_hsa04210 | 0.40199534 |
120 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.39721863 |
121 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.37904620 |
122 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.37206139 |
123 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.37047636 |
124 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.36307339 |
125 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.35860958 |
126 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.35636335 |
127 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.34883436 |
128 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.34878781 |
129 | Prion diseases_Homo sapiens_hsa05020 | 0.34524178 |
130 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.34177649 |
131 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.32860579 |
132 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.30401112 |
133 | RNA transport_Homo sapiens_hsa03013 | 0.29949096 |